Trial record 18 of 2467 for: Diabetes | "Diabetes Mellitus, Insulin-Dependent"
Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01227460|
Recruitment Status : Completed
First Posted : October 25, 2010
Last Update Posted : May 21, 2014
University of Colorado Denver School of Medicine Barbara Davis Center
Information provided by (Responsible Party):
Satish K. Garg, University of Colorado Denver School of Medicine Barbara Davis Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||July 2011|
Publications of Results:
Garg SK, Moser EG, Bode BW, Klaff LJ, Hiatt WR, Beatson C, Snell-Bergeon JK. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial. Endocr Pract. 2013 Jan-Feb;19(1):19-28. doi: 10.4158/EP12100.OR.